Home > Healthcare > Pharmaceuticals > Finished Drug Form > Joint Pain Injections Market

Joint Pain Injections Market Size

Report ID: GMI5403
Published Date: Oct 2024
Report Format: PDF

Download Free Sample

Joint Pain Injections Market Size

The global joint pain injections market size was valued at USD 3.6 billion in 2023 and is anticipated to expand at 7.7% CAGR from 2024 to 2032. The growing elderly population, combined with a rise in orthopedic issues, is poised to significantly drive the growth of the joint pain injections market.

To get key market trends

Download Free Sample

As reported by the World Health Organization, in 2022, around 1.71 billion people worldwide were affected by musculoskeletal disorders. With the aging population on the rise, the prevalence of musculoskeletal conditions and their related functional limitations is escalating. Furthermore, swift technological advancements, alongside surging demand, are set to fuel market growth in the coming years.

Joint pain injections are intra-articular treatments targeting inflammatory joint conditions, including rheumatoid arthritis, psoriatic arthritis, and osteoarthritis. These injections encompass hyaluronic acid, corticosteroids, and platelet-rich plasma.

Joint Pain Injections Market Report Attributes
Report Attribute	Details
Base Year:	2023
Joint Pain Injections Market Size in 2023:	USD 3.6 Billion
Forecast Period:	2024 – 2032
Forecast Period 2024 – 2032 CAGR:	7.7%
2024 – 2032 Value Projection:	USD 7.2 Billion
Historical Data for:	2018 – 2023
No. of Pages:	180
Tables, Charts & Figures:	210
Segments covered:	Injection Type, Joint Type, End Use, and Region
Growth Drivers:	Growing prevalence of sleep apnea and related co-morbidities Rising demand for portable, efficient and superior sleep apnea devices Insurance coverage for treatment of sleep apnea and other sleep disorders Growing awareness regarding sleep apnea and other sleep disorders Increasing aging population Product innovation strategy adopted by key industry players
Pitfalls & Challenges:	Clinical consequences and economic impact of sleep apnea and related sleep disorders Lack of adherence to sleep apnea treatment

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global joint pain injections industry was valued at USD 3.6 billion in 2023 and is anticipated to grow at a 7.7% CAGR from 2024 to 2032, driven by an increasing elderly population and a rise in orthopedic issues.

The hyaluronic acid injections segment held a 64.8% revenue share in 2023 and is projected to expand at a 7.9% CAGR during the forecast period due to the aging population and the development of technologically advanced products.

The North America joint pain injections industry held a 47.4% share in 2023 and is set to witness substantial growth, primarily due to the increasing prevalence of arthritis and other bone-related issues, coupled with the rapid adoption of new products.

Key players in the industry include Anika Therapeutics, Inc., Arthrex, Bioventus, Emcyte Corporation, Ferring B.V., Lifecore Biomedical, OrthogenRx, Pacira BioSciences (Flexion), and Pfizer, Inc.